This forum was held on April 29, 2009, at The Women's Building in San Francisco. An executive summary of the forum is available here (PDF, 207 KB).
Join us for a conversation on the science and controversies surrounding the use of anti-HIV drugs to prevent the HIV transmission and acquisition. Recent studies offer evidence and raise questions about the role of antiretroviral medications in curbing the spread of HIV. Are HIV-positive people who take antiretroviral drugs less likely to transmit the virus? Can these same drugs taken by HIV-negative people help keep them negative? And if so, what are the ethical, financial, and health issues surrounding these HIV prevention strategies? Join us for a conversation on the science and controversies surrounding the use of anti-HIV drugs to prevent HIV transmission and acquisition.
HIVision is an ongoing forum series bringing research and evidence to bear on timely policy and programmatic issues. As thinking on HIV/AIDS continues to evolve, HIVision provides a safe venue to engage the community on potentially controversial topics.
Lisa C. Capaldini, M.D.
Clinic Director, Castro Medical Group
Assistant Clinical Professor of Medicine, UCSF
Clinical Instructor, UCSF Department of Nursing
Moupali Das-Douglas, M.D.
Director of Research, HIV Prevention Section, SFDPH
Assistant Clinical Professor, AIDS/Infectious Diseases, UCSF
Robert Grant, M.D.
Investigator, Gladstone Institute of Virology & Immunology
Associate Professor, UCSF
Dana Van Gorder
Executive Director, Project InformModerated By:
Judith Auerbach, Ph.D.
Vice President, Science & Public Policy, San Francisco AIDS Foundation